MANAGEMENT OF ADVERSE REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

Authors
JUNG AC PAAUW DS
Citation
Ac. Jung et Ds. Paauw, MANAGEMENT OF ADVERSE REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Archives of internal medicine, 154(21), 1994, pp. 2402-2406
Citations number
53
Categorie Soggetti
Medicine, General & Internal
Journal title
Archives of internal medicine → ACNP
ISSN journal
00039926
Volume
154
Issue
21
Year of publication
1994
Pages
2402 - 2406
Database
ISI
SICI code
0003-9926(1994)154:21<2402:MOARTT>2.0.ZU;2-W
Abstract
Trimethoprim-sulfamethoxazole is an important medication for the treat ment and prevention of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Use of this medication has be en limited by the high frequency of adverse reactions that occur in pa tients with human immunodeficiency virus disease. This article reviews the incidence and spectrum of adverse reactions and options for conti nuing therapy with trimethoprim-sulfamethoxazole in human immunodefici ency virus-infected patients who have adverse reactions.